New Delhi, March 04, 2022: WuXi STA – a subsidiary of WuXi AppTec – today announced that its drug product…
Shanghai, January 21, 2022: WuXi STA, a subsidiary of WuXi AppTec, today announced its first parenteral formulation manufacturing line at the Wuxi…
Shanghai, December 03, 2021: WuXi STA – a subsidiary of WuXi AppTec– and Coherent Biopharma, announced the signing of a strategic…
State-of-the-art facility expands WuXi STA's capacity and capability for this novel modality, providing a one-stop shop from preclinical to commercial …
Shanghai, July 23, 2019: STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – announces that its Analytical Service Unit…
Shanghai, May 22, 2019: STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Dizal Pharmaceutical,…
STA will accelerate process R&D and manufacturing of late phase and commercial targets New Delhi, March 25, 2019: STA Pharmaceutical…
New Delhi, March 10, 2019: STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Ark…
New Delhi, February 21, 2019: STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec – and BioLingus, a Swiss…
Shanghai, July 29, 2018: STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec, announces that its Active Pharmaceutical Ingredient (API)…